Imvax, Inc. Publishes Groundbreaking Preclinical Research in Journal for ImmunoTherapy of Cancer
PHILADELPHIA, PA — Imvax, Inc., a clinical-stage biotechnology company, announced the recent publication of preclinical research with IGV-001 in Journal for ImmunoTherapy of Cancer, the official journal of the Society …
Imvax, Inc. Publishes Groundbreaking Preclinical Research in Journal for ImmunoTherapy of Cancer Read More